LeJeune Puetz Investment Counsel’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $3.88M | Buy |
52,150
+1,153
| +2% | +$85.7K | 1.39% | 16 |
|
|
2022
Q4 | $4.75M | Buy |
50,997
+300
| +0.6% | +$28K | 1.77% | 10 |
|
|
2022
Q3 | $4.84M | Buy |
50,697
+410
| +0.8% | +$39.1K | 1.99% | 10 |
|
|
2022
Q2 | $4.66M | Buy |
50,287
+655
| +1% | +$60.7K | 1.81% | 11 |
|
|
2022
Q1 | $5.02M | Hold |
49,632
| – | – | 1.75% | 12 |
|
|
2021
Q4 | $5.12M | Buy |
49,632
+200
| +0.4% | +$20.6K | 1.73% | 11 |
|
|
2021
Q3 | $4.2M | Buy |
49,432
+1,750
| +4% | +$149K | 1.53% | 15 |
|
|
2021
Q2 | $3.98M | Buy |
47,682
+390
| +0.8% | +$32.5K | 1.47% | 15 |
|
|
2021
Q1 | $3.56M | Buy |
47,292
+5,070
| +12% | +$381K | 1.4% | 19 |
|
|
2020
Q4 | $2.88M | Buy |
42,222
+2,225
| +6% | +$152K | 1.24% | 25 |
|
|
2020
Q3 | $2.34M | Buy |
39,997
+2,205
| +6% | +$129K | 1.14% | 27 |
|
|
2020
Q2 | $2.46M | Sell |
37,792
-3,750
| -9% | -$244K | 1.28% | 21 |
|
|
2020
Q1 | $2.47M | Buy |
41,542
+1,395
| +3% | +$82.8K | 1.44% | 17 |
|
|
2019
Q4 | $2.98M | Buy |
40,147
+2,130
| +6% | +$158K | 1.4% | 19 |
|
|
2019
Q3 | $2.4M | Buy |
38,017
+850
| +2% | +$53.6K | 1.22% | 23 |
|
|
2019
Q2 | $2.03M | Buy |
37,167
+4,013
| +12% | +$219K | 1.05% | 33 |
|
|
2019
Q1 | $1.79M | Buy |
33,154
+7,776
| +31% | +$419K | 0.97% | 37 |
|
|
2018
Q4 | $1.66M | Buy |
25,378
+2,080
| +9% | +$136K | 1.04% | 33 |
|
|
2018
Q3 | $1.83M | Buy |
23,298
+1,633
| +8% | +$129K | 1.06% | 32 |
|
|
2018
Q2 | $1.39M | Sell |
21,665
-740
| -3% | -$47.6K | 0.86% | 46 |
|
|
2018
Q1 | $1.39M | Buy |
22,405
+640
| +3% | +$39.8K | 0.86% | 46 |
|
|
2017
Q4 | $1.58M | Buy |
21,765
+140
| +0.6% | +$10.2K | 0.97% | 38 |
|
|
2017
Q3 | $1.76M | Sell |
21,625
-600
| -3% | -$48.8K | 1.13% | 30 |
|
|
2017
Q2 | $1.79M | Sell |
22,225
-200
| -0.9% | -$16.1K | 1.21% | 27 |
|
|
2017
Q1 | $1.76M | Buy |
22,425
+341
| +2% | +$26.8K | 1.26% | 24 |
|
|
2016
Q4 | $1.74M | Buy |
+22,084
| New | +$1.74M | 1.34% | 20 |
|